Back
Corporate News
Concord Biotech's Dholka unit clears Russian GMP inspection
26-Jul-2025, 10:02
Concord Biotech announced the successful completion of the Russian GMP (Good Manufacturing Practice) inspection at our Active Pharmaceutical Ingredient (API) manufacturing facility located in Dholka, Gujarat. The inspection was conducted from July 22' 2025 to July 25' 2025.
Concord Biotech announced the successful completion of the Russian GMP (Good Manufacturing Practice) inspection at our Active Pharmaceutical Ingredient (API) manufacturing facility located in Dholka, Gujarat. The inspection was conducted from July 22' 2025 to July 25' 2025.
Powered by Capital Market - Live News